DFMO Approved for PBS Listing
Neuroblastoma Australia is pleased to announce that DFMO is approved by the Pharmaceutical Benefits Advisory Committee (PBAC) for listing on the Pharmaceutical Benefits Scheme (PBS).
Neuroblastoma Australia is pleased to announce that DFMO is approved by the Pharmaceutical Benefits Advisory Committee (PBAC) for listing on the Pharmaceutical Benefits Scheme (PBS).